GSK Oncology Exec Hoos Heads Back To Biotech As CEO Of Scorpion Therapeutics

After leading oncology teams at GlaxoSmithKline and Bristol Myers Squibb, Axel Hoos, M.D., Ph.D., is heading back to biotech.